| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.24B | $1.02B | $895.10M | $769.20M | $1.04B |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | $273.86M | $172.94M | -$40.35M | $216.10M | $495.92M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $67.85M | $44.52M | -$1.63M | $47.64M | $113.33M |
| Net Income | $259.62M | $151.49M | -$27.52M | $168.68M | $422.98M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |